Larisa Y. Poluektova

Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis.

Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis.

OTK18 expression in brain mononuclear phagocytes parallels the severity of HIV-1 encephalitis.

Neuroregulatory events follow adaptive immune-mediated elimination of HIV-1-infected macrophages: studies in a murine model of viral encephalitis.

Macrophage-induced inflammation affects hippocampal plasticity and neuronal development in a murine model of HIV-1 encephalitis.

Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis.

Protection from the toxicity of diisopropylfluorophosphate by adeno-associated virus expressing acetylcholinesterase.

CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice.

Nano-NRTIs: efficient inhibitors of HIV type-1 in macrophages with a reduced mitochondrial toxicity.

Loss of neuronal integrity during progressive HIV-1 infection of humanized mice.

IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS.

Can Humanized Mice Reflect the Complex Pathobiology of HIV-Associated Neurocognitive Disorders?

Cisplatin-loaded core cross-linked micelles: comparative pharmacokinetics, antitumor activity, and toxicity in mice.

Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.

Antiviral peptide nanocomplexes as a potential therapeutic modality for HIV/HCV co-infection.

Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection.

Improved visualization of neuronal injury following glial activation by manganese enhanced MRI.

Nano-NRTIs demonstrate low neurotoxicity and high antiviral activity against HIV infection in the brain.

Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice.

Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations.

Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized mice.

Manganese-Enhanced Magnetic Resonance Imaging Reflects Brain Pathology During Progressive HIV-1 Infection of Humanized Mice.

Liver-targeted antiviral peptide nanocomplexes as potential anti-HCV therapeutics.

Influence of age, irradiation and humanization on NSG mouse phenotypes.

The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy.

Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary.

Simple and reliable genotyping protocol for mouse Prkdc(SCID) mutation.

Smoothened Agonist Reduces Human Immunodeficiency Virus Type-1-Induced Blood-Brain Barrier Breakdown in Humanized Mice.

Neuropharmacologic Approaches to Restore the Brain's Microenvironment.

Acetaldehyde Disrupts Interferon Alpha Signaling in Hepatitis C Virus-Infected Liver Cells by Up-Regulating USP18.

A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy.

Sonic Hedgehog mimetic prevents leukocyte infiltration into the CNS during acute HIV infection.

Systemic HIV-1 infection produces a unique glial footprint in humanized mouse brains.

Human hepatocyte depletion in the presence of HIV-1 infection in dual reconstituted humanized mice.

Creation of a long-acting nanoformulated dolutegravir.

Antiretroviral Drug Metabolism in Humanized PXR-CAR-CYP3A-NOG Mice.

Persistent EcoHIV infection induces nigral degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice.

Hepatitis C Virus-Infected Apoptotic Hepatocytes Program Macrophages and Hepatic Stellate Cells for Liver Inflammation and Fibrosis Development: Role of Ethanol as a Second Hit.

Liver as a target of human immunodeficiency virus infection.

Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infection.

Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression.

Human Interleukin-34 facilitates microglia-like cell differentiation and persistent HIV-1 infection in humanized mice.

Immune Activations and Viral Tissue Compartmentalization During Progressive HIV-1 Infection of Humanized Mice.

Acetaldehyde suppresses the display of HBV-MHC class I complexes on HBV-expressing hepatocytes.

Small molecule ONC201 inhibits HIV-1 replication in macrophages via FOXO3a and TRAIL.

Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice.

Eluted 25-hydroxyvitamin D from radially aligned nanofiber scaffolds enhances cathelicidin production while reducing inflammatory response in human immune system-engrafted mice.